Biofrontera Inc. (BFRIW) stock
BFRIWNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as BFRI
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026Score 10/30
$0.00+0.00 (0.00%)
Close on Oct 30, 2026Market cap $12.96MP/E –Yield –
Biofrontera net income
Net income is the profit left for shareholders after every expense, interest and tax.
Biofrontera's net income for the twelve months ending Jun 30, 2026 was -$6.37M. For fiscal 2025 it was -$10.54M. The highest annual figure on record is -$640.00K in fiscal 2022.
Annual net income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$10.54M | – |
| FY2024 | Dec 31, 2024 | -$17.76M | – |
| FY2023 | Dec 31, 2023 | -$20.13M | – |
| FY2022 | Dec 31, 2022 | -$640.00K | – |
| FY2021 | Dec 31, 2021 | -$37.71M | – |
| FY2020 | Dec 31, 2020 | -$10.99M | – |
Quarterly net income
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$604.00K | – |
| Q1 FY2026 | Mar 31, 2026 | -$4.75M | – |
| Q4 FY2025 | Dec 31, 2025 | $5.64M | – |
| Q3 FY2025 | Sep 30, 2025 | -$6.65M | – |
| Q2 FY2025 | Jun 30, 2025 | -$5.32M | – |
| Q1 FY2025 | Mar 31, 2025 | -$4.20M | – |
| Q4 FY2024 | Dec 31, 2024 | -$1.40M | -139.6% |
| Q3 FY2024 | Sep 30, 2024 | -$5.67M | – |
| Q2 FY2024 | Jun 30, 2024 | -$257.00K | – |
| Q1 FY2024 | Mar 31, 2024 | -$10.44M | – |
| Q4 FY2023 | Dec 31, 2023 | $3.53M | – |
| Q3 FY2023 | Sep 30, 2023 | -$6.34M | – |
| Q2 FY2023 | Jun 30, 2023 | -$9.84M | – |
| Q1 FY2023 | Mar 31, 2023 | -$7.48M | -234.5% |
| Q4 FY2022 | Dec 31, 2022 | -$2.79M | – |
| Q3 FY2022 | Sep 30, 2022 | -$2.57M | – |
| Q2 FY2022 | Jun 30, 2022 | -$850.00K | – |
| Q1 FY2022 | Mar 31, 2022 | $5.56M | – |
| Q4 FY2021 | Dec 31, 2021 | -$14.51M | – |
| Q3 FY2021 | Sep 30, 2021 | -$16.01M | – |
| Q2 FY2021 | Jun 30, 2021 | -$3.66M | – |
| Q1 FY2021 | Mar 31, 2021 | -$3.53M | – |
| Q4 FY2020 | Dec 31, 2020 | -$186.00K | – |
| Q3 FY2020 | Sep 30, 2020 | -$2.99M | – |